Yale University’s Pulmonx LUNG Stock Holding History

Yale University’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,097	Closed	-$370K	–	17
2021 Q1	$370K	Buy	+8,097	New	+$464K	0.8%	8

Other funds holding LUNG

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Yale University's LUNG Position: Q2 2021 in Review

Yale University sold out of Pulmonx (LUNG) in Q2 2021, closing a stake of 8,097 shares — an estimated $370K sold.

Yale University first reported a position in LUNG in Q1 2021 and held it in 1 quarter. The position peaked at $370K in Q1 2021. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2021.

Yale University reported no remaining Pulmonx position as of Q2 2021 after selling out during the quarter.
Yale University sold 8,097 Pulmonx shares in Q2 2021, an estimated $370K.
Yale University first reported a position in Pulmonx in Q1 2021 and held it in 1 quarter.
Yale University's Pulmonx position peaked at $370K in Q1 2021.
113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2021.

Based on Yale University's 13F filing for Q2 2021, filed 13 Aug 2021.